JP Morgan Chase
BBNX

JP Morgan Chase’s Beta Bionics BBNX Stock Holding History

JP Morgan Chase’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
703,356
+396,127
+129% +$4.71M ﹤0.01% 2651
2026
Q1 		$3.03M Sell
307,229
-41,442
-12% -$613K ﹤0.01% 3765
2025
Q4 		$10.6M Buy
348,671
+142,716
+69% +$3.81M ﹤0.01% 2621
2025
Q3 		$4.09M Buy
205,955
+199,785
+3,238% +$3.51M ﹤0.01% 3534
2025
Q2 		$89.8K Sell
6,170
-90
-1% -$1.27K ﹤0.01% 5652
2025
Q1 		$76.6K Buy
+6,260
New +$117K ﹤0.01% 5694

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

JP Morgan Chase's BBNX Position: Q2 2026 in Review

JP Morgan Chase increased its Beta Bionics (BBNX) stake by 129% in Q2 2026, buying an estimated $4.71M and bringing the position to 703,356 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

JP Morgan Chase first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • JP Morgan Chase held 703,356 shares of Beta Bionics worth $12M as of Q2 2026.
  • JP Morgan Chase bought 396,127 Beta Bionics shares in Q2 2026, an estimated $4.71M.
  • Beta Bionics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2651 holding.
  • JP Morgan Chase first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.